Tekwani B L, Bacchi C J, Pegg A E
Department of Cellular & Molecular Physiology, Milton S. Hershey Medical Center Pennsylvania State University College of Medicine, Hershey 17033.
Mol Cell Biochem. 1992 Nov 4;117(1):53-61. doi: 10.1007/BF00230410.
Trypanosoma brucei brucei contained a S-adenosyl-L-methionine decarboxylase (AdoMetDC) strongly activated by putrescine. The enzyme was also activated to a lesser extent by cadaverine and 1,3-diaminopropane. Spermidine and spermine had no effect on basal activity of the enzyme. However, they interfered with putrescine activation of trypanosomal AdoMetDC. The trypanosomal enzyme could not be precipitated with antiserum against human AdoMetDC. The trypanosomal AdoMetDC enzyme subunit was labeled by reaction with 35S-decarboxylated AdoMet in the presence of NaCNBH4, and found to have a molecular weight of 34 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The subunit was readily degraded on storage to a form with a molecular weight of 26 kDa. The specificity of labeling of AdoMetDC by this procedure was confirmed by the prevention of 35S-decarboxylated S-adenosylmethionine (AdoMet) binding in the presence of specific AdoMetDC inhibitors [either methylglyoxal bis(guanylhydrazone (MGBG), a reversible inhibitor, or 5'-deoxy-5'-[(2-hydrazinoethyl)methylamino]adenosine (MHZEA), an irreversible inactivator]. As compared to human AdoMetDC, the trypanosomal enzyme showed weaker binding to a column of MGBG-Sepharose and also was significantly less sensitive to inhibition by MGBG and its congener ethylglyoxal bis(guanylhydrazone) (EGBG). Thus, the trypanosomal AdoMetDC differs significantly from its mammalian and bacterial counterparts and may therefore be exploited as a specific target for chemotherapy of trypanosomiasis.
布氏布氏锥虫含有一种受腐胺强烈激活的S-腺苷-L-甲硫氨酸脱羧酶(AdoMetDC)。该酶也受到尸胺和1,3-二氨基丙烷较小程度的激活。亚精胺和精胺对该酶的基础活性没有影响。然而,它们会干扰锥虫AdoMetDC的腐胺激活作用。锥虫的这种酶不能用抗人AdoMetDC的抗血清沉淀。在NaCNBH4存在的情况下,锥虫AdoMetDC酶亚基通过与35S-脱羧AdoMet反应进行标记,在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上发现其分子量为34 kDa。该亚基在储存时很容易降解为分子量为26 kDa的形式。在特异性AdoMetDC抑制剂[可逆抑制剂甲基乙二醛双(胍基腙)(MGBG)或不可逆失活剂5'-脱氧-5'-[(2-肼基乙基)甲基氨基]腺苷(MHZEA)]存在的情况下,35S-脱羧S-腺苷甲硫氨酸(AdoMet)结合被阻止,从而证实了该方法对AdoMetDC标记的特异性。与人类AdoMetDC相比,锥虫的这种酶与MGBG-琼脂糖柱的结合较弱,并且对MGBG及其同系物乙基乙二醛双(胍基腙)(EGBG)的抑制也明显不敏感。因此,锥虫AdoMetDC与其哺乳动物和细菌对应物有显著差异,因此可能被用作治疗锥虫病化疗的特异性靶点。